<DOC>
	<DOCNO>NCT02049424</DOCNO>
	<brief_summary>Outcome evaluation patient underwent transplantation T-repleted bone marrow post-transplantation cyclophosphamide</brief_summary>
	<brief_title>Observational Study Patients Who Underwent Haploidentical Transplantation With T-repleted Bone Marrow</brief_title>
	<detailed_description>Patients underwent transplantation T-repleted bone marrow haploidentical transplantation analyze consider toxicity incidence ( GVHD , infective complication , graft-failure incidence TRM ) efficacy variable ( Overall Survival , Progression Free Survival Relapse incidence )</detailed_description>
	<criteria>patient affect hematologic neoplasia underwent haploidentical transplantation ( 23 mismatch ) familiar donor , nonex vivo manipulate bone marrow posttransplantation cyclophosphamide ex vivo manipulate bone marrow transplantation use antilymphocyte serum conditioning</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>